I am confident management have a plan in regard to timing and news flow.
Not sure if they will be able to make your financial decision a sure thing though . The over subscriptions from sophs may well cover what the retail does not .
Any problem with regard to FDA and start up will surely hurt , that is the market risk .
Left field announcements could come into play .
Thanks for the factual info Max.
BLT Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held